In a filing, Collegium Pharmaceutical Inc revealed its EVP and General Counsel Kuhlmann Shirley R. unloaded Company’s shares for reported $0.91 million on Jan 10 ’25. In the deal valued at $33.04 per share,27,500 shares were sold. As a result of this transaction, Kuhlmann Shirley R. now holds 119,184 shares worth roughly $3.76 million.
Then, Kuhlmann Shirley R. bought 27,500 shares, generating $908,628 in total proceeds.
Before that, Smith Thomas B sold 9,593 shares. Collegium Pharmaceutical Inc shares valued at $351,320 were divested by the EVP and Chief Medical Officer at a price of $36.62 per share. As a result of the transaction, Smith Thomas B now holds 53,816 shares, worth roughly $1.7 million.
Needham upgraded its Collegium Pharmaceutical Inc [COLL] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in late July from “a Neutral” to “a Buy”. Jefferies also remained covering COLL and has increased its forecast on June 07, 2024 with a “Buy” recommendation from previously “Hold” rating. Piper Sandler revised its rating on May 10, 2024. It rated COLL as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of COLL
On Tuesday, Collegium Pharmaceutical Inc [NASDAQ:COLL] saw its stock jump 3.47% to $31.58. Over the last five days, the stock has gained 2.10%. Collegium Pharmaceutical Inc shares have risen nearly 10.23% since the year began. Nevertheless, the stocks have fallen -5.28% over the past one year. While a 52-week high of $42.29 was reached on 01/10/25, a 52-week low of $28.39 was recorded on 01/03/25. SMA at 50 days reached $31.02, while 200 days put it at $33.89.
Levels Of Support And Resistance For COLL Stock
The 24-hour chart illustrates a support level at 30.22, which if violated will result in even more drops to 28.85. On the upside, there is a resistance level at 32.33. A further resistance level may holdings at 33.07. The Relative Strength Index (RSI) on the 14-day chart is 50.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.80, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 55.61%. Stochastics %K at 22.46% indicates the stock is a holding.
How much short interest is there in Collegium Pharmaceutical Inc?
A steep rise in short interest was recorded in Collegium Pharmaceutical Inc stocks on 2025-01-31, dropping by -0.3 million shares to a total of 5.68 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-31 was 5.98 million shares. There was a decline of -5.31%, which implies that there is a negative sentiment for the stock.
